IP Library Granted Patent US 8,852,875
Granted Patent B2
US 8,852,875 · App. 12/596,768 · Granted Oct 7, 2014

Methods for counting cells

Inventors: Mehmet Toner (Wellesley, MA); Rashid Bashir (Champaign, IL); Xuanhong Cheng (Charlestown, MA); Utkan Demirci (Cambridge, MA); Daniel Irimia (Charlestown, MA); William R. Rodriguez (Cambridge, MA); Liju Yang (Apex, NC); Lee Zamir (Cambridge, MA); Yi-Shao Liu (Champaign, IL)
Assignees: The General Hospital Corporation; Purdue Research Foundation
G01N33/5005G01N15/1056G01N2015/1062G01N33/84G01N2015/1006G01N15/1484G01N15/1031
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,852,875
App. No.
12/596,768
Granted
Oct 7, 2014
Kind
B2
Abstract

The invention features methods of quantifying cells in a sample by lysing the cells followed by the measurement of at least one intracellular component. Methods of the invention are especially useful for quantifying small numbers of cells, e.g., over a large surface area or volume compared to the cell size. In a preferred embodiment, methods of the invention are performed using a microfluidic device.

Claims (22)

1. A method of counting mammalian cells in a sample, the method comprising:

introducing the sample into a channel, wherein a surface of the channel is coated with binding moieties that bind specifically to a cell surface marker of the mammalian cells;

immobilizing the mammalian cells in the channel by allowing the mammalian cells to bind to the binding moieties;

introducing an isotonic, low conductivity solution into the channel to reduce background conductivity in the channel;

measuring an impedance baseline in the channel;

lysing the cells in the channel by replacing the isotonic, low conductivity solution in the channel with a hypotonic, low conductivity solution; and

measuring an impedance in the channel after cell lysis, a change in impedance from the impedance baseline is indicative of the number of mammalian cells lysed in the channel.

2. The method of claim 1 , wherein measuring the impedance baseline and the impedance in the channel after cell lysis both comprise applying an electric field to the channel at a single frequency between about 100 Hz and about 10 kHz.

3. The method of claim 1 , wherein the change in impedance occurs as a result of a release of intracellular ions from the mammalian cells as a result of the lysing.

4. The method of claim 1 , wherein the change in impedance occurs as a result of a release of nuclei from the mammalian cells as a result of the lysing.

5. The method of claim 1 , wherein measuring the impedance baseline and the impedance in the channel after cell lysis both comprise using an electrode selected from the group consisting of: a top down electrode, an interdigitated (IDT) electrode, and a two rail electrode.

6. The method of claim 1 , wherein the mammalian cells comprise CD4+ lymphocytes and the binding moieties comprise anti-CD4 antibodies.

7. The method of claim 1 , wherein the sample comprises a heterogeneous mixture of cells.

8. The method of claim 7 , wherein the sample is blood.

9. The method of claim 1 , wherein the isotonic, low conductivity solution comprises about 8.5% sucrose and about 0.3% dextrose.

10. The method of claim 1 , wherein the hypotonic, low conductivity solution comprises about 2% sucrose and about 0.07% dextrose.

11. The method of claim 1 , wherein the hypotonic, low conductivity solution comprises a detergent.

12. The method of claim 1 , wherein the channel is a closed microfluidic channel.

13. The method of claim 1 , wherein a change in impedance between the impedance baseline and the impedance in the channel after cell lysis is caused by a change in bulk conductivity of the sample in the channel.

14. The method of claim 1 , wherein an impedance of the isotonic, low-conductivity solution is greater than 1 kΩ.

15. The method of claim 1 , wherein an impedance of the isotonic, low-conductivity solution is greater than 10 kΩ.

16. The method of claim 1 , wherein an impedance of the isotonic, low-conductivity solution is greater than 1 MΩ.

Assignments (3)
CONFIRMATORY LICENSE Recorded Jun 4, 2020
From: MASSACHUSETTS GENERAL HOSPITAL
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 052833/0824 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 13, 2011
From: TONER, MEHMET; CHENG, XUANHONG; DEMIREI, UTKAN; IRIMIA, DANIEL; RODRIGUEZ, WILLIAM; ZAMIR, LEE
To: THE GENERAL HOSPITAL CORPORATION
Reel/Frame 026119/0941 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 13, 2011
From: BASHIR, RASHID; YANG, LIJU; LIU, YI-SHAO
To: PURDUE RESEARCH FOUNDATION
Reel/Frame 026120/0001 →
Continuity (2)
Provisional Application 60925368 · Apr 20, 2007
Related Publication 20120003687A1 · Jan 5, 2012